N-acetyl Glutamate - Synthetase: Clinical Trials

1 trial for N-acetyl Glutamate - Synthetase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow N-acetyl Glutamate - Synthetase: new trials by email Literature Review of N-acetyl Glutamate - Synthetase trials Research Report on N-acetyl Glutamate - Synthetase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD
KRRO-121, Placebo - Urea Cycle Disorders, Inborn, Urea Cycle Disorders
Phase 1 / Phase 2RecruitingKorro Bio, Inc.302026-09-282026-10-08

Narrower conditions

Adult-onset citrullinemia type 2 (1)  ·  Argininosuccinic Aciduria (1)  ·  Hyperargininemia (1)  ·  N-acetyl glutamate synthetase deficiency (1)  ·  Ornithine Carbamoyltransferase Deficiency Disease (1)  ·  Urea Cycle Disorders, Inborn (1)

Broader conditions

Amino Acid Metabolism, Inborn Errors (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Sponsors

Korro Bio, Inc. (1)

Countries

Australia (1)